REVANCE THERAPEUTICS INC shareholders Q3 2023

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

REVANCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Cape Investment Advisory, Inc. 447$5,1270.00%
Qube Research & Technologies Ltd 114,250$1,310,4480.00%
STATE OF WISCONSIN INVESTMENT BOARD 78,032$895,0270.00%
Graham Capital Management, L.P. 10,612$121,7190.00%
Renaissance Technologies 178,500$2,0470.00%
Nuveen Asset Management, LLC 603,497$6,922,1110.00%
BlackRock Inc. 6,756,720$77,499,5790.00%
Baird Financial Group, Inc. 61,586$706,3910.00%
COMMONWEALTH EQUITY SERVICES, LLC 99,129$1,1370.00%
BNP PARIBAS FINANCIAL MARKETS 142,302$1,632,2040.00%
Swiss National Bank 184,750$2,119,0820.00%
DekaBank Deutsche Girozentrale 86,100$1,0120.00%
GEODE CAPITAL MANAGEMENT, LLC 1,780,277$20,422,4020.00%
FMR LLC 1,894,107$21,725,4070.00%
SEI INVESTMENTS CO 73,609$844,2830.00%
Stephens Consulting, LLC 500$5,7350.00%
WELLINGTON MANAGEMENT GROUP LLP 1,082,420$12,415,3580.00%
CREDIT SUISSE AG/ 140,615$1,612,8540.00%
CAPITAL FUND MANAGEMENT S.A. 41,900$480,5930.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 663,538$7,610,7810.00%
External links

This page lists REVANCE THERAPEUTICS INC's shareholders in Q3 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.